Breaking News Instant updates and real-time market news.

VEON

Veon

$3.05

(0.00%)

, HFC

HollyFrontier

$68.91

(0.00%)

09:40
07/17/18
07/17
09:40
07/17/18
09:40

Unusually active option classes on open July 17th

Unusual total active option classes on open include: VEON Ltd (VEON), HollyFrontier (HFC), Gold Bear 3x (DUST), UnitedHealth (UNH), Johnson & Johnson (JNJ), Caesars (CZR), Goldman Sachs (GS), McDonald's (MCD), Activision Blizzard (ATVI), and GDM (GDX).

VEON

Veon

$3.05

(0.00%)

HFC

HollyFrontier

$68.91

(0.00%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$25.49

(0.00%)

UNH

UnitedHealth

$257.03

(0.00%)

JNJ

Johnson & Johnson

$124.70

(0.00%)

CZR

Caesars

$11.63

(0.00%)

GS

Goldman Sachs

$231.01

(0.00%)

MCD

McDonald's

$158.76

(0.00%)

ATVI

Activision Blizzard

$80.23

(0.00%)

GDX

Market Vector Gold Miners

$21.88

(0.00%)

  • 17

    Jul

  • 17

    Jul

  • 01

    Aug

  • 02

    Aug

  • 02

    Aug

  • 08

    Aug

VEON Veon
$3.05

(0.00%)

07/03/18
JPMS
07/03/18
UPGRADE
Target $4
JPMS
Overweight
Veon upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alexei Gogolev upgraded Veon to Overweight and raised his price target for the shares to $4 from $2.80. The company shed its Italian business at a "very attractive price," Gogolev tells investors in a research note. The analyst likes management's focus on deleveraging.
07/03/18
07/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Albemarle (ALB) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the selloff in companies tied to lithium is overdone. 2. Veon (VEON) upgraded to Overweight from Neutral at JPMorgan with analyst Alexei Gogolev stating that the company shed its Italian business at a "very attractive price". 3. Roku (ROKU) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms. 4. Amedisys (AMED) upgraded to Buy from Neutral at BofA/Merrill with analyst Joanna Gajuk stating that last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. 5. NetEase (NTES) upgraded to Overweight from Underweight at JPMorgan with analyst Alex Yao saying he expects NetEase to end a six-quarter "earnings downgrade cycle" with its "lackluster" earnings growth starting to recover in Q2 and peaking in Q1 of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/18
GSCO
07/05/18
UPGRADE
Target $4
GSCO
Buy
Veon upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Vyacheslav Degtyarev upgraded Veon to Buy from Neutral and raised his price target to $4.00 from $2.90. The analyst says the company's sale of a 50% stake in JV Wind Tre to Hutchison for EUR 2.45B "highlights management's willingness to create shareholder value through portfolio simplification". Degtyarev adds that despite the 13% rise in Veon stock price following the announcement, the current share price still does not reflect the management's commitment to a "strategic shift".
06/21/18
BOFA
06/21/18
DOWNGRADE
BOFA
Neutral
Veon downgraded to Neutral from Buy at BofA/Merrill
HFC HollyFrontier
$68.91

(0.00%)

06/29/18
USCA
06/29/18
UPGRADE
USCA
Overeight
HollyFrontier upgraded to Overeight from Hold at US Capital Advisors
05/24/18
ARGS
05/24/18
NO CHANGE
Target $85
ARGS
Buy
HollyFrontier price target raised to $85 from $56 at Argus
Argus analyst Bill Selesky raised his price target on HollyFrontier to $85 and kept his Buy rating after its Q1 earnings beat. The analyst contends that the "swing to profitability" reflected higher crude oil volumes and refining margins, along with a full quarter of contribution from the recently-purchased Petro-Canada Lubricants business. Selesky also raises his FY18 EPS view to $4.78 from $3.66 after the Q1 beat as well as the improving end-market conditions for the company.
06/04/18
FBCO
06/04/18
NO CHANGE
Target $85
FBCO
Neutral
HollyFrontier price target raised to $85 from $70 at Credit Suisse
Credit Suisse analyst Manav Gupta raised his price target for HollyFrontier to $85 from $70 saying the Widening Brent-WTI, Midland-Cushing, RIN waivers and RIN price crash and continued benefits of improvement in refining reliability are all working in the company's favor. The analyst reiterates an Outperform rating on the shares.
06/04/18
FBCO
06/04/18
NO CHANGE
Target $85
FBCO
Neutral
HollyFrontier price target raised to $85 from $70 at Credit Suisse
Credit Suisse analyst Manav Gupta raised his price target for HollyFrontier to $85 from $70 saying the Widening Brent-WTI, Midland-Cushing, RIN waivers and RIN price crash and continued benefits of improvement in refining reliability are all working in the company's favor. The analyst reiterates a Neutral rating on the shares.
DUST Direxion Daily Gold Miners Bear 3X ETF
$25.49

(0.00%)

UNH UnitedHealth
$257.03

(0.00%)

06/28/18
CANT
06/28/18
NO CHANGE
CANT
Amazon deal not to materially impact managed care segment, says Cantor Fitzgerald
Following the announcement that Amazon (AMZN) is acquiring PillPack, Cantor Fitzgerald analyst Steven Halper notes that back in April, CNBC had reported that Walmart (WMT) and Amazon were both looking to acquire the company, with Walmart likely to pay under $1B for PillPack. At this juncture, the analyst is not worried about Amazon's entrance into the prescription market and does not expect a material impact on any of the companies he covers in the managed care segment. Halper reiterates an Overweight rating of Aetna (AET), Anthem (ANTM), Centene (CNC), UnitedHealth (UNH) and Wellcare (WCG). He keeps a Neutral rating on Humana (HUM).
07/05/18
CANT
07/05/18
NO CHANGE
Target $300
CANT
Overweight
UnitedHealth shares 'remain very attractive,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper reiterates an Overweight rating on UnitedHealth with a $300 price target ahead of the company's Q2 results. The company kicks off the Q2 reporting season on July 17 and should report "strong" results, continuing the trend from Q1, Halper tells investors in a pre-earnings research note. The shares "remain very attractive," the analyst adds.
07/10/18
PIPR
07/10/18
NO CHANGE
PIPR
Risk adjuster suspension positive for Centene and Molina, says Piper Jaffray
Centers for Medicare & Medicaid Services suspending risk adjusters for the health exchange will likely cost the government and consumers more, but it could be positive for Centene (CNC) and Molina Healthcare (MOH), Piper Jaffray analyst Sarah James tells investors in a research note. Both companies are in a net payable position for 2017 and not having to pay these funds would allow the plans to retain cash, the analyst adds. James also sees a positive read-through for UnitedHealth (UNH), Aetna (AET) and Cigna (CI). The analyst finds it most likely that CMS will seek to adjust the risk adjusters in the end rather than cancel the program, but she adds the agency only has a few weeks for them to sort this out, which she feels is not enough time.
07/11/18
JEFF
07/11/18
NO CHANGE
Target $74
JEFF
Buy
Teladoc price target raised to $74 from $49 at Jefferies
Jefferies analyst Sean Dodge raised his price target for Teladoc (TDOC) to $74 saying he' "increasingly bullish" following meetings with management. The company's new "Surround Sound" member engagement strategy continues to drive utilization improvements, Dodge tells investors in a research note. Further, the analyst sees potential upside from Teladoc's relationship with UnitedHealth (UNH), which he believes it "set to blossom." Dodge keeps a Buy rating on Teladoc shares.
JNJ Johnson & Johnson
$124.70

(0.00%)

07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/12/18
GSCO
07/12/18
UPGRADE
GSCO
Neutral
Johnson & Johnson upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jami Rubin upgraded Johnson & Johnson (JNJ) to Neutral with an unchanged price target of $134. The shares closed yesterday down $1.11 to $126.24. The stock is down 10% year-to-date and 15% from its recent all-time high of $148, Rubin tells investors in a research note. She notes J&J is trading in line with the large cap Pharmaceuticals group at 15 times 2019 estimates. The company's non-operational earnings revisions are now better understood by investors at current share levels, Rubin contends. The analyst this morning also downgraded Perrigo (PRGO) to Sell from Neutral.
07/12/18
07/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the stock is down 10% year-to-date and 15% from its recent all-time high of $148. 2. Hallmark Financial (HALL) upgraded to Outperform from Market Perform at Raymond James. 3. Transocean (RIG), Ensco (ESV), and Rowan Companies (RDC) were upgraded to Buy from Hold at Tudor Pickering. 4. Precision Drilling (PDS) and Nabors Industries (NBR) were upgraded to Overweight from Equal Weight at Morgan Stanley. 5. CA Technologies (CA) upgraded to Market Perform from Underperform at Wells Fargo and Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/18
FBCO
07/13/18
NO CHANGE
Target $151
FBCO
Outperform
J&J verdict likely to increase attention on lawsuits, says Credit Suisse
After a Missouri jury on Thursday ordered Johnson & Johnson to pay $4.69B to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer, Credit Suisse analyst Vamil Divan said the large number of ongoing litigations are gaining the attention of investors and is not expected to slow. Given the number of cases related to both talc and mesh and the size of the potential verdicts, Divan says it is "challenging" to put reasonable ranges on what J&J's ultimate liability may end up being, though he notes that J&J has been able to overturn many of the cases and has appealed all of the unfavorable verdicts. Divan maintains an Outperform rating and $151 price target.
CZR Caesars
$11.63

(0.00%)

05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
05/24/18
JPMS
05/24/18
INITIATION
Target $16
JPMS
Overweight
Caesars initiated with an Overweight at JPMorgan
JPMorgan analyst Dan Politzer started Caesars Entertainment with an Overweight rating and $16 price target. The company's Las Vegas Strip renovations should boost the average daily rate and improve customer mix, Politzer tells investors in a research note. He also sees opportunity for Caesars to improve margins at regional properties. The analyst views the stock as attractively valued at current levels.
06/19/18
OPCO
06/19/18
NO CHANGE
Target $15
OPCO
Outperform
Caesars runway for growth remains strong, says Oppenheimer
Oppenheimer analyst Ian Zaffino said Caesars management sees significant upside from the legalization of sports betting, though they note the ramp could be mild. Management also remains confident Caesars can deliver above-market RevPAR growth and near-industry-leading margins. Following his management meetings, Zaffino remains bullish on Caesars and maintains an Outperform rating and $15 price target on the shares.
05/24/18
05/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Broadcom (AVGO) initiated with an Outperform at Evercore ISI. 2. Caesars (CZR) initiated with an Overweight at JPMorgan. 3. e.l.f. Beauty (ELF) initiated with an Outperform at Oppenheimer. 4. uniQure (QURE) initiated with a Buy at SunTrust. 5. Marinus Pharmaceuticals (MRNS) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
GS Goldman Sachs
$231.01

(0.00%)

04/18/18
BMOC
04/18/18
NO CHANGE
Target $245
BMOC
Market Perform
Goldman Sachs price target raised to $245 from $221 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs (GS) to $245 after the company's Q1 revenue beat, saying it is "back to stealing market share in its core business" as its FICC - fixed income, currencies, and commodities - trading rose 23% vs. a 4% decline for peers. The analyst adds that while Goldman Sachs will continue to experience positive operating leverage, its valuation relative to Morgan Stanley (MS) cannot be justified, favoring the latter based on its greater exposure to higher-multiple asset management businesses. Fotheringham keeps his Market Perform rating on Goldman Sachs.
06/20/18
DBAB
06/20/18
UPGRADE
Target $76
DBAB
Buy
Citi upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Citi (C) to Buy and raised his price target for the shares to $76 from $74. The analyst also calls Goldman Sachs (GS) and Wells Fargo (WFC) his top picks ahead of the Q2 reporting season.
06/29/18
OPCO
06/29/18
NO CHANGE
Target $88
OPCO
Outperform
Oppenheimer says 'particularly pleased' with Citi's $17.6B share buyback
Following the release of CCAR results for 2018, Oppenheimer analysts Chris Kotowski and Ben Chittenden told investors in a research note that they are "particularly pleased" with Citi's (C) $17.6B share buyback, up 13% from last year and above their $16.5B estimate, while the dividend increase to 45c was also 5c better than expected. The analysts noted that both Goldman (GS) and Morgan Stanley (MS) got "conditional passes" on their capital plans, as both banks "ran a bit afoul" of the supplementary leverage ratio limitation.
06/22/18
OPCO
06/22/18
NO CHANGE
OPCO
Outperform
CIT a 'clear winner' of Dodd-Frank Stress Tests, says Oppenheimer
Oppenheimer analyst Chris Kotowski noted that Dodd-Frank Stress Test results were released last night and all 35 banks passed. As a result, he told investors in a research note that he does not expect the industry's ability to return capital to be significantly impacted, supporting his view that banks outperform the broader market as the capital returns mean higher ROTCEs, lower share count and higher EPS. Kotowski contended that one clear winner this year is CIT (CIT), as the CCAR limit was increased to $100B, and thus CIT is now exempt, but noted that on the adverse side, Goldman (GS) "squeaked by" with a 5.6% minimum CET 1.
MCD McDonald's
$158.76

(0.00%)

07/11/18
WELS
07/11/18
NO CHANGE
Target $180
WELS
Outperform
McDonald's price target lowered to $180 from $185 at Wells Fargo
Wells Fargo analyst Jon Tower lowered his price target for McDonald's to $180 from $185 ahead of quarterly results. The analyst reiterates an Outperform rating on the shares.
07/11/18
CLVD
07/11/18
DOWNGRADE
CLVD
Neutral
McDonald's downgraded to Neutral from Buy at Cleveland Research
07/11/18
07/11/18
DOWNGRADE

Neutral
Cleveland Research downgrades McDonald's as checks lower confidence in upside
As previously reported, Cleveland Research analyst Steven Gojak downgraded McDonald's to Neutral from Buy after his industry checks led him to believe that its comparable sale results in the second half will trend more in-line with consensus expectations. Gojak, who is still modeling Q2 U.S. comp sales growth of 3.7% for McDonald's, which is above the 3.1% consensus growth view, lowered his 2018 U.S. comp estimate to 3.2% from 3.4%, compared to the consensus of 3.1% growth. He also cut his 2019 comp estimate to up 3%, down from up 3.5% and only slightly above the 2.9% consensus growth estimate.
07/11/18
07/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MCDONALD'S CUT TO NEUTRAL: Cleveland Research analyst Steven Gojak downgraded McDonald's (MCD) to Neutral from Buy after his industry checks led him to believe that its comparable sale results in the second half will trend more in-line with consensus expectations. Gojak, who is still modeling Q2 U.S. comp sales growth of 3.7% for McDonald's, which is above the 3.1% consensus growth view, lowered his 2018 U.S. comp estimate to 3.2% from 3.4%, compared to the consensus of 3.1% growth. McDonald's is down 1% in midday trading. NOMURA INITIATES INTERNET SECTOR: Nomura Instinet initiated coverage on the Americas Internet sector. Nomura Instinet initiated Alphabet Class A (GOOGL), Facebook (FB), and Spotify (SPOT) with Buy ratings, and added that Alphabet and Facebook were the best positioned in this newly regulated industry. It initiated Twitter (TWTR) with a Reduce rating, saying that while it is a "stable long-term asset that has something for everyone," the firm believes the market is pricing in "a significant advertising reacceleration that implies a shift in ad spend," while the firm expects "stability instead of a reacceleration of growth." CREDIT SUISSE POSITIVE ON VERIZON, NEGATIVE ON AT&T: Credit Suisse analyst Douglas Mitchelson initiated Verizon (VZ) with an Outperform rating and a price target of $58. The analyst believes Verizon should benefit from its "major $10B cost savings plan, stable capex spending, record low churn, and the benefit of tax reform." Mitchelson also initiated AT&T (T) with an Underperform rating and a price target of $29. Mitchelson said that AT&T will require greater scale and a shift to global direct-to-consumer distribution, stating that the elevated execution risk under its ownership structure and its wireless business look mature with little chance for stabilization in spite of the coming 5G technology. DISNEY VALUATION NOT COMPELLING: Credit Suisse analyst Douglas Mitchelson initiated Disney (DIS) with a Neutral rating and a price target of $114. The analyst noted that the company is "the best positioned traditional media company", but believes the Street has not sufficiently discounted the costs associated with Disney's push into direct-to-consumer streaming services, adding that FY19 will be extra challenging because of high film comps and major theme park project launches.
ATVI Activision Blizzard
$80.23

(0.00%)

06/28/18
UBSW
06/28/18
NO CHANGE
UBSW
Buy
Activision, Electronic Arts targets raised on 'Gaming-as-a-Service' shift at UBS
UBS analyst Eric Sheridan see the video game industry on the cusp of a transformation in its business model towards "Gaming-as-a-Service" along with streaming and subscriptions, which he views as supportive of sustainable revenue growth, margin expansion and more stable and predictable free cash flow. Though still in its early days as an industry, esports has exhibited "promising signs," added Sheridan, who raised his price target on Activision Blizzard (ATVI) to $88 from $76 and his target on Electronic Arts (EA) to $176 from $146. He maintains Buy ratings on both game maker's stocks.
07/12/18
MSCO
07/12/18
NO CHANGE
Target $80
MSCO
Overweight
Morgan Stanley calls Overwatch deal with Disney an 'important step' for esports
Morgan Stanley analyst Brian Nowak said Activision Blizzard's (ATVI) exclusive live television coverage deal with Disney (DIS) for the Overwatch League not only has the potential to drive higher licensing revenue for the company but its also an "important step" in continuing to establish esports as more of a mainstream event and towards his $100 per share "bull case" for Activision shares. Nowak maintains an Overweight rating and $80 price target on Activision Blizzard shares.
06/25/18
PIPR
06/25/18
NO CHANGE
PIPR
Overweight
Video game revenue could be ~100% digital by 2022, says Piper Jaffray
Piper Jaffray analyst Michael Olson told investors in a research note that by 2022 there is a high likelihood that ~100% of video game revenue will be digital, adding that publisher margins could be dramatically higher if this is the case. Based on the implied share prices resulting from his 100% digital calendar year 2022 EPS scenario, Olson believes this would be a tailwind for Activision (ATVI), EA (EA) and Take-Two (TTWO) and that the average 3-yr share price CAGR for the video game group would be 17%. Olson maintained an Overweight rating on Activision, EA and Take-Two.
07/11/18
GSCO
07/11/18
NO CHANGE
Target $82
GSCO
Buy
Activision Blizzard mobile game could add $7/share in value, says Goldman Sachs
Goldman Sachs analyst Christopher Merwin believes Activision (ATVI) is focused on increasing its exposure to the mobile market. While Activision already has a successful mobile business with King, the analyst thinks there is a large and untapped opportunity to repurpose PC- and console-based IP for a mobile audience. Merwin also believes Blizzard in particular intends to bring mobile titles to the Chinese market, where there is a well-traveled path of game publishers like NetEase (NTES) and Tencent (TCEHY) transitioning established PC franchises into mobile hits. Overall, Merwin sees a Blizzard mobile game adding 30c in incremental EPS to Activision by 2020, or $7/share in value. He reiterates a Buy rating and $82 price target on Activision Blizzard's shares.
GDX Market Vector Gold Miners
$21.88

(0.00%)

TODAY'S FREE FLY STORIES

VLKAY

Volkswagen

$0.00

(0.00%)

, WMT

Walmart

$97.89

-0.74 (-0.75%)

19:37
08/19/18
08/19
19:37
08/19/18
19:37
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

VLKAY

Volkswagen

$0.00

(0.00%)

WMT

Walmart

$97.89

-0.74 (-0.75%)

MSFT

Microsoft

$107.58

-0.07 (-0.07%)

TCEHY

Tencent

$0.00

(0.00%)

STT

State Street

$84.95

0.73 (0.87%)

TWX

Acquired by T

$0.00

(0.00%)

KSS

Kohl's

$76.43

1.68 (2.25%)

BV

BrightView

$17.49

-0.06 (-0.34%)

VZ

Verizon

$54.79

0.51 (0.94%)

ABBV

AbbVie

$98.79

0.6 (0.61%)

LYB

LyondellBasell

$113.07

1.155 (1.03%)

AVGO

Broadcom

$209.27

0.6 (0.29%)

RF

Regions Financial

$19.48

0.09 (0.46%)

SBUX

Starbucks

$53.58

0.53 (1.00%)

CF

CF Industries

$47.52

0.25 (0.53%)

MOS

Mosaic

$29.64

(0.00%)

NTR

Nutrien

$55.95

0.94 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 06

    Nov

VJET

voxeljet

$3.34

-0.17 (-4.84%)

19:14
08/19/18
08/19
19:14
08/19/18
19:14
Recommendations
voxeljet analyst commentary at Piper Jaffray »

voxeljet Q2 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEG

Key Energy

$12.97

-0.03 (-0.23%)

18:30
08/19/18
08/19
18:30
08/19/18
18:30
Hot Stocks
Key Energy appoints Rob Saltiel as new President, CEO »

Key Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 02

    Oct

  • 03

    Oct

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$35.61

-0.05 (-0.14%)

16:52
08/19/18
08/19
16:52
08/19/18
16:52
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' wins weekend with $25.2M debut »

Warner Bros. (TWX)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$35.61

-0.05 (-0.14%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$54.88

1.055 (1.96%)

FOX

21st Century Fox

$44.83

-0.28 (-0.62%)

FOXA

21st Century Fox

$45.37

-0.34 (-0.74%)

LGF.A

Lionsgate

$22.95

-0.11 (-0.48%)

DIS

Disney

$112.44

-0.05 (-0.04%)

VIAB

Viacom

$30.72

0.62 (2.06%)

VIA

Viacom

$35.60

0.1 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

SHLD

Sears

$1.32

-0.135 (-9.28%)

12:28
08/19/18
08/19
12:28
08/19/18
12:28
Periodicals
Sears CEO wants board to sell him Kenmore, pay off debt, WSJ reports »

Sears CEO Edward Lampert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

13:37
08/18/18
08/18
13:37
08/18/18
13:37
Periodicals
Walmart asks beauty suppliers to consider sourcing outside of China, Reuters say »

Walmart has asked some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

13:26
08/18/18
08/18
13:26
08/18/18
13:26
Periodicals
Tencent-backed Qutoutiao files for U.S. IPO, Reuters reports »

Chinese content…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

13:10
08/18/18
08/18
13:10
08/18/18
13:10
Periodicals
Selloff in Chinese internet stocks may shake faith in FANG, Reuters says »

A steep downturn in…

FB

Facebook

$173.78

-0.98 (-0.56%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

NFLX

Netflix

$316.78

-5.51 (-1.71%)

GOOG

Alphabet

$1,199.79

-6.21 (-0.51%)

GOOGL

Alphabet Class A

$1,215.50

-8.05 (-0.66%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 13

    Sep

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

VLKAY

Volkswagen

$0.00

(0.00%)

13:05
08/18/18
08/18
13:05
08/18/18
13:05
Periodicals
Volkswagen CEO was told about emissions software months before, Reuters reports »

Volkswagen CEO Herbert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, TCEHY

Tencent

$0.00

(0.00%)

13:01
08/18/18
08/18
13:01
08/18/18
13:01
Hot Stocks
Walmart, Flipkart announce completion of investment »

Walmart (WMT) and…

WMT

Walmart

$97.89

-0.74 (-0.75%)

TCEHY

Tencent

$0.00

(0.00%)

MSFT

Microsoft

$107.58

-0.07 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

BBOX

Black Box

$1.64

0.09 (5.81%)

12:57
08/18/18
08/18
12:57
08/18/18
12:57
Hot Stocks
Black Box announces sale agreement of Federal Government IT Services Business »

Black Box announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

$76.43

1.68 (2.25%)

12:52
08/18/18
08/18
12:52
08/18/18
12:52
Periodicals
Kohl's looking to break cycle, Barron's says »

Kohl's is set to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

STT

State Street

$84.95

0.73 (0.87%)

12:47
08/18/18
08/18
12:47
08/18/18
12:47
Periodicals
State Street selloff looks overdone, Barron's says »

At the moment, State…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$97.89

-0.74 (-0.75%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

12:42
08/18/18
08/18
12:42
08/18/18
12:42
Periodicals
May be time to sell Walmart, Barron's says »

In a follow-up story,…

WMT

Walmart

$97.89

-0.74 (-0.75%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Sep

VZ

Verizon

$54.79

0.51 (0.94%)

12:39
08/18/18
08/18
12:39
08/18/18
12:39
Periodicals
Verizon remains 'reasonably' priced, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CF

CF Industries

$47.52

0.25 (0.53%)

, MOS

Mosaic

$29.64

(0.00%)

12:36
08/18/18
08/18
12:36
08/18/18
12:36
Periodicals
CF, Mosaic gains have just begun, Barron's says »

CF Industries (CF),…

CF

CF Industries

$47.52

0.25 (0.53%)

MOS

Mosaic

$29.64

(0.00%)

NTR

Nutrien

$55.95

0.94 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 06

    Nov

ABBV

AbbVie

$98.79

0.6 (0.61%)

, LYB

LyondellBasell

$113.07

1.155 (1.03%)

12:25
08/18/18
08/18
12:25
08/18/18
12:25
Periodicals
StAbbVie, Starbucks among dividend standouts, Barron's says »

AbbVie (ABBV),…

ABBV

AbbVie

$98.79

0.6 (0.61%)

LYB

LyondellBasell

$113.07

1.155 (1.03%)

AVGO

Broadcom

$209.27

0.6 (0.29%)

RF

Regions Financial

$19.48

0.09 (0.46%)

SBUX

Starbucks

$53.58

0.53 (1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

BV

BrightView

$17.49

-0.06 (-0.34%)

12:21
08/18/18
08/18
12:21
08/18/18
12:21
Periodicals
Sunny outlook for BrightView, Barron's says »

BrightView's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

, CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

11:18
08/18/18
08/18
11:18
08/18/18
11:18
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

HOG

Harley-Davidson

$42.26

1.15 (2.80%)

CSIQ

Canadian Solar

$13.12

0.02 (0.15%)

FSLR

First Solar

$50.98

0.18 (0.35%)

JASO

JA Solar

$0.00

(0.00%)

SUNEQ

SunEdison

$0.00

(0.00%)

SPWR

SunPower

$6.65

0.06 (0.91%)

TSL

Trina Solar

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.